Alynylam Pharmaceuticals (ALNY +3.3%) trades higher after the firm releases positive results...
Alynylam Pharmaceuticals (ALNY +3.3%) trades higher after the firm releases positive results from clinical tests of its cholesterol-reducing treatment. The firm says it will continue the study with increased dosages.
From other sites
Video at CNBC.com (Mon, 6:49AM)
at CNBC.com (Jan 12, 2015)
at CNBC.com (Nov 17, 2014)
at CNBC.com (Oct 13, 2014)
at CNBC.com (Sep 2, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs